University of California San Diego alumnus David Goeddel, ’72, and his wife Alena, have donated $7.5 million to drive leading-edge research, discovery and training in the UC San Diego School of Biological Sciences, which includes support for the newly named Goeddel Family Technology Sandbox.
An international team of researchers, led by scientists at UC San Diego, report that a gene therapy that inhibits targeted nerve cell signaling effectively reduced neuropathic pain with no detectable side effects in mice with spinal cord or peripheral nerve injuries.
School of Biological Sciences neurobiologist Yishi Jin and molecular biologist James T. Kadonaga have been elected to the National Academy of Sciences, one of the highest honors bestowed upon U.S. scientists and engineers.
UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
On April 28, more than 100+ startups and business leaders convened in Petco Park to engage with the diversity, variety and ambition of the regional life sciences and technology startup scene. UC San Diego featured the largest representation of startups at the event.
Traumatic brain injuries might have faded from the headlines since the NFL reached a $765 million settlement for concussion-related brain injuries, but professional football players aren’t the only ones impacted by these injuries.
Bioengineers and cardiologists from UC San Diego invented a technology that can accurately and noninvasively map atrial and ventricular heart arrhythmias in a matter of minutes. The technology demonstrated 97.3 percent accuracy in a clinical validation study, and recently received FDA clearance.
Using second-long electrical shocks, UC San Diego scientists were able to control the types of cells in a community of bacteria. Being able to direct the ratio of cells holds implications for settings spanning agriculture to health care, where antibiotic resistance is a significant threat.